Is Thermo Fisher Scientific (TMO) overvalued or fairly valued?

MarketChacha shows Thermo Fisher Scientific's valuation in context — a forward P/E of about 19.3, a price-to-book of about 3.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Thermo Fisher Scientific (TMO)?

Thermo Fisher Scientific last traded at $526.23 (-1.2% on the day), as of 7/20/2026 — a delayed quote shown for education, not investment advice.

Thermo Fisher Scientific

TMO · NYSE · Life Sciences · United States

$526.23-1.2%

Delayed · as reported by Yahoo Finance · as of Jul 20, 2026, 8:00 PM

Snapshot

TickerTMO

ExchangeNYSE

SectorLife Sciences

IndustryDiagnostics & Research

CountryUnited States

Employees125,000

HeadquartersWaltham, United States

Market cap$195.6B

P/B3.8

Volume1.18M

Websitewww.thermofisher.com

Filings tracked0

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.2%
Institutions93.9%
Public & other5.9%

3,502 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.19%
Vanguard Capital Management LLC6.53%
State Street Corporation4.50%
Morgan Stanley2.92%
FMR, LLC2.90%
Geode Capital Management, LLC2.26%
Franklin Resources, Inc.1.83%
JPMORGAN CHASE & CO1.83%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $12.0B · EPS 6.37

Est. earnings growth +10.0%

Next fiscal year

Rev $50.3B · EPS 27.26

Est. earnings growth +9.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$403.3652-wk range$643.99

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about TMO

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.